AAAAAA
Results: 26-50/103
Authors:
YOULE MS
HIGGS CJ
GAZZARD BG
LANT AF
Citation: Ms. Youle et al., RENAL EXCRETION AND PHARMACOKINETICS OF FOSCARNET IN HIV-SEROPOSITIVEPATIENTS - EFFECT OF PROBENECID PRETREATMENT, British journal of clinical pharmacology, 43(1), 1997, pp. 112-115
Authors:
CARTLEDGE JD
MIDGLEY J
PETROU M
SHANSON D
GAZZARD BG
Citation: Jd. Cartledge et al., UNRESPONSIVE HIV-RELATED ORO-ESOPHAGEAL CANDIDOSIS - AN EVALUATION OF2 NEW IN-VITRO AZOLE SUSCEPTIBILITY TESTS, Journal of antimicrobial chemotherapy, 40(4), 1997, pp. 517-523
Authors:
CARTLEDGE JD
MIDGLEY J
GAZZARD BG
Citation: Jd. Cartledge et al., CLINICAL-RESPONSE TO KETOCONAZOLE OF HIV-RELATED ORAL CANDIDOSIS IS PREDICTED BY ODDS RELATIVE GROWTH METHOD OF SUSCEPTIBILITY TESTING, Journal of antimicrobial chemotherapy, 40(1), 1997, pp. 117-119
Authors:
DEWIT S
DUPONT B
CARTLEDGE JD
HAWKINS DA
GAZZARD BG
CLUMECK N
DENNING DW
Citation: S. Dewit et al., A DOSE COMPARISON STUDY OF A NEW TRIAZOLE ANTIFUNGAL (D0870) IN HIV-POSITIVE PATIENTS WITH ORAL CANDIDIASIS, AIDS, 11(6), 1997, pp. 759-763
Authors:
CARTLEDGE JD
MIDGLEY J
GAZZARD BG
Citation: Jd. Cartledge et al., ITRACONAZOLE CYCLODEXTRIN SOLUTION - THE ROLE OF IN-VITRO SUSCEPTIBILITY TESTING IN PREDICTING SUCCESSFUL TREATMENT OF HIV-RELATED FLUCONAZOLE-RESISTANT AND FLUCONAZOLE-SUSCEPTIBLE ORAL CANDIDOSIS, AIDS, 11(2), 1997, pp. 163-168
Authors:
CHENE G
EASTERBROOK PJ
JUSZCZAK E
YU LM
POCOCK SJ
GAZZARD BG
Citation: G. Chene et al., LONG-TERM SURVIVAL IN PATIENTS WITH ADVANCED IMMUNODEFICIENCY, AIDS, 11(2), 1997, pp. 209-216
Authors:
CARTLEDGE JD
MIDGLEY J
GAZZARD BG
Citation: Jd. Cartledge et al., CLINICALLY SIGNIFICANT AZOLE CROSS-RESISTANCE IN CANDIDA ISOLATES FROM HIV-POSITIVE PATIENTS WITH ORAL CANDIDOSIS, AIDS, 11(15), 1997, pp. 1839-1844
Authors:
SADLER M
MORRISJONES S
NELSON M
GAZZARD BG
Citation: M. Sadler et al., SUCCESSFUL TREATMENT OF CYTOMEGALOVIRUS ENCEPHALITIS IN AN AIDS PATIENT USING CIDOFOVIR, AIDS, 11(10), 1997, pp. 1293-1294
Authors:
CARTLEDGE JD
MIDGLEY J
GAZZARD BG
Citation: Jd. Cartledge et al., PRIOR FLUCONAZOLE EXPOSURE AS AN INDEPENDENT RISK FACTOR FOR FLUCONAZOLE RESISTANT CANDIDOSIS IN HIV-POSITIVE PATIENTS - A CASE-CONTROL STUDY, Genitourinary medicine, 73(6), 1997, pp. 471-474
Authors:
MOYLE GJ
GAZZARD BG
Citation: Gj. Moyle et Bg. Gazzard, SURROGATE MARKERS NOW PROVIDE PHYSICIANS WITH THE BEST MEANS TO MANAGE ANTIRETROVIRAL THERAPY - THE CASE FOR, Genitourinary medicine, 73(3), 1997, pp. 216-218
Authors:
VONAU B
BARTON SE
GAZZARD BG
Citation: B. Vonau et al., SHARING PRESCRIBING OF CONTINUOUS ACYCLOVIR TREATMENT - EFFECTS OF A NEW POLICY AND GENERAL-PRACTITIONER RESPONSES, Genitourinary medicine, 73(3), 1997, pp. 225-226
Authors:
MOORE DAJ
GAZZARD BG
NELSON MR
Citation: Daj. Moore et al., CENTRAL VENOUS LINE INFECTIONS IN AIDS, The Journal of infection, 34(1), 1997, pp. 35-40
Authors:
NEILD PJ
GAZZARD BG
Citation: Pj. Neild et Bg. Gazzard, HIV-1 INFECTION IN CHINA, Lancet, 350(9082), 1997, pp. 963-963
Authors:
GAZZARD BG
MOYLE G
Citation: Bg. Gazzard et G. Moyle, BRITISH-HIV-ASSOCIATION GUIDELINES FOR ANTIRETROVIRAL TREATMENT OF HIV-SEROPOSITIVE INDIVIDUALS - REPLY, Lancet, 349(9068), 1997, pp. 1838-1839
Authors:
GAZZARD BG
MOYLE GJ
WEBER J
JOHNSON M
BINGHAM JS
BRETTLE R
CHURCHILL D
FISHER M
GRIFFIN G
JEFFERIES D
KING E
GORMER R
LEE C
POZNIAK A
SMITH JR
TUDORWILLIAMS G
WILLIAMS I
Citation: Bg. Gazzard et al., BRITISH HIV ASSOCIATION GUIDELINES FOR ANTIRETROVIRAL TREATMENT OF HIV-SEROPOSITIVE INDIVIDUALS, Lancet, 349(9058), 1997, pp. 1086-1092
Authors:
CARTLEDGE JD
MIDGELY J
GAZZARD BG
Citation: Jd. Cartledge et al., ITRACONAZOLE SOLUTION - HIGHER SERUM DRUG CONCENTRATIONS AND BETTER CLINICAL-RESPONSE RATES THAN THE CAPSULE FORMULATION IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME PATIENTS WITH CANDIDOSIS, Journal of Clinical Pathology, 50(6), 1997, pp. 477-480
Authors:
NEILD PJ
JEWKES R
GAZZARD BG
Citation: Pj. Neild et al., GASTRIC-EMPTYING IN HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTED INDIVIDUALS - RELATIONSHIP TO SYMPTOMS, AUTONOMIC FUNCTION AND GASTROINTESTINAL (GI) PATHOGENS, Gut, 40, 1997, pp. 176-176
Authors:
NEILD PJ
WESTABY D
SANSOM H
PADLEY S
GAZZARD BG
Citation: Pj. Neild et al., BILIARY MANOMETRY IN AIDS-RELATED CHOLANGITIS (ARC) - RELATIONSHIP TOSYMPTOMS AND RADIOLOGICAL FINDINGS, Gut, 40, 1997, pp. 267-267
Authors:
SEDDON BM
PADLEY SP
GAZZARD BG
Citation: Bm. Seddon et al., DIFFERENTIAL-DIAGNOSIS OF PAROTID MASSES IN HIV-POSITIVE MEN - REPORTOF 5 CASES AND REVIEW, International journal of STD & AIDS, 7(3), 1996, pp. 224-227
Authors:
SHARPSTONE DR
DUGGAL A
GAZZARD BG
Citation: Dr. Sharpstone et al., INFLAMMATORY BOWEL-DISEASE IN INDIVIDUALS SEROPOSITIVE FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS, European journal of gastroenterology & hepatology, 8(6), 1996, pp. 575-578
Authors:
CARTLEDGE JD
MIDGLEY J
GAZZARD BG
Citation: Jd. Cartledge et al., RELATIVE GROWTH MEASUREMENT OF CANDIDA SPECIES IN A SINGLE CONCENTRATION OF FLUCONAZOLE PREDICTS THE CLINICAL-RESPONSE TO FLUCONAZOLE IN HIV-INFECTED PATIENTS WITH ORAL CANDIDOSIS, Journal of antimicrobial chemotherapy, 37(2), 1996, pp. 275-283
Authors:
SHARPSTONE DR
ROWBOTTOM AW
NELSON MR
LEPPER MW
GAZZARD BG
Citation: Dr. Sharpstone et al., FECAL TUMOR-NECROSIS-FACTOR-ALPHA IN INDIVIDUALS WITH HIV-RELATED DIARRHEA, AIDS, 10(9), 1996, pp. 989-994
Authors:
UTHAYAKUMAR S
BOWER M
MONEYKYRLE J
MUYSHONDT C
YOULE M
HANNON F
PHILLIPS R
GAZZARD BG
BOAG F
Citation: S. Uthayakumar et al., RANDOMIZED CROSS-OVER COMPARISON OF LIPOSOMAL DAUNORUBICIN VERSUS OBSERVATION FOR EARLY KAPOSIS-SARCOMA, AIDS, 10(5), 1996, pp. 515-519
Authors:
GAZZARD BG
Citation: Bg. Gazzard, WASTING IN HIV DISEASE - PROGRESS TOWARDS RATIONAL MANAGEMENT STRATEGY, AIDS, 10, 1996, pp. 111-111
Authors:
WALSH JC
NEWELL AM
NELSON MR
GAZZARD BG
Citation: Jc. Walsh et al., RENAL-FAILURE IN HIV DISEASE - PRECIPITANTS, OUTCOMES AND EFFECT ON SURVIVAL, AIDS, 10, 1996, pp. 120-120